Renal Research Institute (RRI) was established in 1997 as a partnership between Fresenius Medical Care (FMC) and Beth Israel Medical Center, New York City. It is an administratively distinct institution which collaborates with a select group of US based dialysis facilities with strong ties to academic research including the University of Michigan, the University of North Carolina, the University of Rochester, Yale University through St. Raphael Hospital in New Haven, CT and their dialysis facilities. RRI trains Research fellows from countries around the world in kidney disease-related clinical research. Its research spans a full spectrum of interests from molecular biology, clinical research, and pharmaceutical trials to epidemiology. The network of international collaborators has made it a global research institution with ties to Europe, Asia, Central and South America and Africa. The Institute is dedicated to improving the outcomes of patients with kidney disease requiring dialysis. RRI members participated in the NIH funded, NCDS, HEMO, CHOICE and FHN trials.
An annual CKD conference has provided a venue for the exchange of ideas for clinicians, scientists, students and fellows since its inception in January 1999 and is in part supported by NIH and FMC grants. The RRI Dialysis Times is circulated to nearly 8,000 CKD professionals.
RRI is working collaboratively with the Sustainable Kidney Care Foundation (SKCF) whose mission is “to bring kidney treatment where none exists”, with the major project being in sub-Saharan Africa. To this end collaborators include the International Society of Nephrology, the International Pediatric Nephrology Association and the International Society for Peritoneal Dialysis (ISPD).
© 2001-2012 Renal Research Institute, LLC